Patents by Inventor Carrie A. Costello

Carrie A. Costello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9328087
    Abstract: Methods of preparing a class of oxazolidinones useful to impede bacterial growth are disclosed.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: May 3, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Carrie A. Costello, Jacqueline A. Ware, Robert J. Duguid
  • Publication number: 20140206878
    Abstract: Methods of preparing a class of oxazolidinones useful to impede bacterial growth are disclosed.
    Type: Application
    Filed: November 25, 2013
    Publication date: July 24, 2014
    Applicant: TRIUS THERAPEUTICS, INC.
    Inventors: Carrie A. Costello, Jacqueline A. Ware, Robert J. Duguid
  • Patent number: 8604209
    Abstract: Methods of preparing a class of oxazolidinones useful to impede bacterial growth are disclosed.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: December 10, 2013
    Assignee: Trius Therapeutics, Inc.
    Inventors: Jacqueline A Ware, Carrie A Costello, Robert J. Duguid, Douglas Phillipson
  • Patent number: 8148548
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: April 3, 2012
    Assignee: Konarka Technologies, Inc.
    Inventors: Steffen Zahn, Richard V. C. Carr, Roberta Kathleen Hause, Carrie A. Costello, Mark Mclaws
  • Patent number: 7982055
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: July 19, 2011
    Assignee: Konarka Technologies, Inc.
    Inventors: Steffen Zahn, Carrie A. Costello, Mark McLaws
  • Publication number: 20100093669
    Abstract: Methods of preparing a class of oxazolidinones useful to impede bacterial growth are disclosed.
    Type: Application
    Filed: October 9, 2009
    Publication date: April 15, 2010
    Applicant: TRIUS THERAPEUTICS
    Inventors: Jacqueline A. Simson, Carrie A. Costello, Robert J. Duguid, Douglas Phillipson
  • Publication number: 20090143599
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Application
    Filed: January 14, 2009
    Publication date: June 4, 2009
    Applicant: AIR PRODUCTS AND CHEMICALS, INC.
    Inventors: Steffen Zahn, Richard V.C. Carr, Roberta Kathleen Hause, Carrie A. Costello, Mark Mclaws
  • Publication number: 20090018348
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Application
    Filed: July 13, 2007
    Publication date: January 15, 2009
    Applicant: Air Products and Chemicals, Inc.
    Inventors: Steffen Zahn, Carrie A. Costello, Mark McLaws
  • Patent number: 7205402
    Abstract: The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: April 17, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Purushotham Vemishetti, Scott T. Chadwick, Carrie A. Costello, Sridhar Desikan, Emily A. Reiff
  • Patent number: 7012158
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of ?-difluoromethylornithine (DFMO) having the formula
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: March 14, 2006
    Assignee: Skinmedica, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Publication number: 20060047115
    Abstract: The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
    Type: Application
    Filed: September 1, 2005
    Publication date: March 2, 2006
    Inventors: Purushotham Vemishetti, Scott Chadwick, Carrie Costello, Sridhar Desikan, Emily Reiff
  • Publication number: 20040171876
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula 1
    Type: Application
    Filed: February 26, 2004
    Publication date: September 2, 2004
    Applicants: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company to Women First Healthcare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Patent number: 6730809
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: May 4, 2004
    Assignee: Women First Healthcare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Publication number: 20030083384
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula 1
    Type: Application
    Filed: August 19, 2002
    Publication date: May 1, 2003
    Applicant: Bristol-Myers Squibb Company to Women First HealthCare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti